<< Read Full Article
<< Read Full Article
Vertex Hep-C Drug Shows Promise
Updated from 9:21 p.m. EDT April 15
One of the big knocks against Vertex Pharmaceuticals(VRTX Quote) has been that the data surrounding its hepatitis C drug telaprevir was a bit thin compared with the hype and expectations enveloping it.
But the divide between hype and reality is definitely starting to narrow, especially after Saturday, when researchers presented new clinical data on telaprevir that shows the drug having a profound, and positive, effect in the treatment of hepatitis C. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.05
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |
Connect with TheStreet